Author Archives: Jason Carr

Capital Power Gets a Hold Rating from Scotiabank

The Utilities sector company, Capital Power (TSX: CPX), has received a rating update from a Wall Street analyst yesterday. Analyst Robert Hope from Scotiabank remains neutral on the stock and has a C$26 price target. According to TipRanks.com, Hope is

Diamondback Receives a Buy from Scotiabank

Scotiabank analyst Peter Kissel maintained a Buy rating on Diamondback (NASDAQ: FANG) yesterday and set a price target of $118. The company’s shares closed yesterday at $109.15. According to TipRanks.com, Kissel is ranked 0 out of 5 stars with an

Scotiabank Keeps a Buy Rating on RSP Permian

In a report released yesterday, Peter Kissel from Scotiabank maintained a Buy rating on RSP Permian (NYSE: RSPP), with a price target of $43. The company’s shares closed yesterday at $36. According to TipRanks.com, Kissel is ranked 0 out of

SM Energy Receives a Hold from Scotiabank

Scotiabank analyst Peter Kissel maintained a Hold rating on SM Energy (NYSE: SM) yesterday and set a price target of $20. The company’s shares closed yesterday at $20.05. According to TipRanks.com, Kissel is ranked 0 out of 5 stars with

Scotiabank Remains a Hold on Approach Resources Inc

Scotiabank analyst Peter Kissel maintained a Hold rating on Approach Resources Inc (NASDAQ: AREX) yesterday and set a price target of $3. The company’s shares closed yesterday at $2.34. According to TipRanks.com, Kissel is ranked 0 out of 5 stars

Analysts Are Bullish on These Healthcare Stocks: CRME, ALIM

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiome Pharma Corp (NASDAQ: CRME), Alimera (NASDAQ: ALIM) and Ligand Pharma (NASDAQ: LGND) with bullish sentiments. Cardiome Pharma Corp (NASDAQ: CRME) In